← Browse by Condition
Medical Condition
glioblastoma
Total Trials
17
Recruiting Now
17
Trial Phases
Phase 2, Phase 1, EARLY_Phase 1
NCT02800486 Phase 2
Recruiting
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Enrollment
37 pts
Location
United States
Sponsor
Northwell Health
NCT06782984
Recruiting
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Enrollment
150 pts
Location
South Korea
Sponsor
Chungnam National University H...
NCT06001281
Recruiting
Predictive Value of Soluble CD146 in Glioblastoma Patients
Enrollment
55 pts
Location
France
Sponsor
Assistance Publique Hopitaux D...
NCT04699773
Recruiting
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Enrollment
32 pts
Location
United States
Sponsor
University of Maryland, Baltim...
NCT07003542 Phase 2
Recruiting
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Enrollment
48 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
NCT05607407 Phase 2
Recruiting
Methimazole in Patients With Progressive Glioblastoma
Enrollment
19 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
NCT05106296 Phase 1
Recruiting
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Enrollment
37 pts
Location
United States
Sponsor
Theodore S. Johnson
NCT06176066 Phase 1
Recruiting
PH Sensitive MRI Based Resections of Glioblastoma
Enrollment
18 pts
Location
United States
Sponsor
University of California, Los ...
NCT05773326 EARLY_Phase 1
Recruiting
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Enrollment
12 pts
Location
United States
Sponsor
Nader Sanai
NCT02394626 Phase 2
Recruiting
Surgery for Recurrent Glioblastoma
Enrollment
120 pts
Location
Austria, France, Ger...
Sponsor
Insel Gruppe AG, University Ho...
NCT06645808 EARLY_Phase 1
Recruiting
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
NCT03603405 Phase 1, Phase 2
Recruiting
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Enrollment
62 pts
Location
United States
Sponsor
The Methodist Hospital Researc...
NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06496971 Phase 3
Recruiting
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Enrollment
32 pts
Location
Taiwan
Sponsor
NaviFUS Corporation
NCT07480941 Phase 1
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
NCT05629702 Phase 2
Recruiting
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Enrollment
120 pts
Location
United Kingdom
Sponsor
University of Birmingham
NCT07420543
Recruiting
Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
Enrollment
30 pts
Location
Italy
Sponsor
Fondazione I.R.C.C.S. Istituto...